ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

FENC Fennec Pharmaceuticals Inc

9,23
0,13 (1,43%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Fennec Pharmaceuticals Inc FENC NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,13 1,43% 9,23 00:00:52
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
9,23 9,15 9,38 9,23 9,10
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
21/3/202411:00GLOBEFennec Pharmaceuticals Reports Full Year and Fourth Quarter..
19/3/202411:01GLOBEFennec Pharmaceuticals to Report Full Year and Fourth..
18/3/202408:00PRNUSFennec Pharmaceuticals and Norgine Enter into Exclusive..
18/3/202402:00GLOBEFennec Pharmaceuticals and Norgine Enter into Exclusive..
06/3/202422:07EDGAR2Form 8-K/A - Current report: [Amend]
29/2/202422:04EDGAR2Form 8-K - Current report
29/2/202413:04GLOBEFennec Pharmaceuticals Reports Preliminary Unaudited Net..
14/2/202416:47EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01/2/202411:55GLOBEFDA Issues Reminder of Non-Substitution of PEDMARK® (sodium..
05/1/202423:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:45EDGAR2Form 144 - Report of proposed sale of securities
04/1/202422:42EDGAR2Form 144 - Report of proposed sale of securities
29/12/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202321:51EDGAR2Form 144 - Report of proposed sale of securities
18/12/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
05/12/202311:55GLOBEFennec Announces Incremental $5 Million Investment from..
16/11/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202322:56EDGAR2Form S-3 - Registration statement under Securities Act of..
09/11/202322:52EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:50GLOBEFennec Pharmaceuticals to Participate in Upcoming Investor..
09/11/202322:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202300:19EDGAR2Form 144 - Report of proposed sale of securities
06/11/202311:59GLOBEFennec Pharmaceuticals Announces Third Quarter 2023..
03/11/202322:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202311:45GLOBEFennec Pharmaceuticals to Report Third Quarter 2023..
07/9/202311:59GLOBEFennec Pharmaceuticals to Participate in Upcoming Investor..
07/8/202323:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202316:51EDGAR2Form 8-K/A - Current report: [Amend]
04/8/202316:58EDGAR2Form 8-K - Current report
04/8/202316:57EDGAR2Form 8-K - Current report
03/8/202311:59GLOBEFennec Pharmaceuticals Announces Second Quarter 2023..
31/7/202311:30GLOBEFennec Pharmaceuticals to Report Second Quarter 2023..
30/6/202322:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202323:00GLOBEFennec Announces Results of Annual Meeting
06/6/202311:44GLOBEFennec Pharmaceuticals Announces European Commission..
11/5/202312:01GLOBEFennec Pharmaceuticals Announces First Quarter 2023..
08/5/202312:15GLOBEFennec Pharmaceuticals to Report First Quarter 2023..

Dernières Valeurs Consultées

Delayed Upgrade Clock